Archive for the ‘Afinitor’ Category

Roche, Novartis showcase game-changing breast cancer drug data

December 8th, 2011 John Carroll

Roche and Novartis ($NVS) put out new data yesterday on two treatments that promise to fundamentally reshape the way the majority of breast cancer patients are treated. Roche clearly impressed specialists and analysts with the news that pertuzumab…

Posted in Afinitor, Blog, breast cancer, Companies, Diagnostics, Funding, Herceptin, Medical Devices, Medical Supply, Novartis, pertuzumab, Pharmaceuticals, Roche, Startups, Universities, Videos Tags: Comments Off
Read More »